aprott/iStock via Getty Images Shares of Hims & Hers ( NYSE: HIMS ) fell 14% Wednesday following news that Novo Nordisk’s ( NVO ) weight-loss drug Wegovy is no longer considered to be in short supply in the U.S. Certain doses of the drug, along with its sibling drug Ozempic, have.
